Refractory Methamphetamine-Induced Psychosis: An Emerging Crisis in Rural America and the Role of Amantadine in

Mayank Gupta1,2, Nihit Gupta3, Michael Esang4

  • 1Psychiatry, Lake Erie College of Osteopathic Medicine, Erie, USA.

Cureus
|April 8, 2022
PubMed

Insights

Methamphetamine (MA) use has risen in rural areas, partly due to opioid restrictions. This increase strains mental health services with complex psychosis cases, requiring updated clinical understanding.

Area of Science:

  • Public Health
  • Neuroscience
  • Psychiatry

Background:

  • Methamphetamine (MA) use has significantly increased in rural America over the past decade.
  • This trend is linked to reduced opioid availability following interventions for the opioid epidemic.
  • Emergence of cheaper alternatives like fentanyl-laced fake prescriptions exacerbates the substance abuse crisis.

Observation:

  • Methamphetamine use is associated with a serious clinical effect: psychosis.
  • Atypical presentations and refractory courses of MA-induced psychosis challenge clinicians.
  • Mental health services are increasingly stretched due to these complex cases.

Findings:

  • Understanding the unique pharmacodynamics and neurotoxicity of MA is critical.
  • Recognizing similarities between MA psychosis and schizophrenia is essential for diagnosis.
  • Evolving empirical evidence highlights the complexity of managing MA-induced psychosis.

Implications:

  • Clinicians need updated knowledge to address the growing challenge of MA psychosis.
  • Effective management strategies for methamphetamine-induced psychosis require further research.
  • Addressing the rural mental health and substance abuse crisis necessitates tailored interventions for MA use.

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
225
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
108
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
492
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
766
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
274
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
414